MedTrace Logo

Carbohydrate Loading in Type 2 Diabetes Mellitus

NCT06687811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-11-14

No results posted yet for this study

Summary

The goal of this clinical trial is to learn the effects of preoperative carbohydrate loading on perioperative blood glucose levels and insulin resistance in type 2 diabetes mellitus undergo elective surgery. The main questions it aims to answer are:

* Does carbohydrate loading affects perioperative blood glucose and insulin resistance in type 2 diabetes mellitus patients undergo surgery?
* How are the incident of perioperative hyperglycemia and hypoglycemia between subjects who receive placebo compared with subjects who receive carbohydrate loading
* How are the hyperglycemia-related complications comparison between two groups?

Researchers will compare the carbohydrate loading intervention to placebo (regular drinking water with zero-calorie sweetener) to see the effects of carbohydrate loading to blood glucose levels and insulin resistance (by HOMA-IR value)

Participants will:

* randomized to carbohydrate loading (CHO) group or placebo
* checked for preoperative, intraoperative, postoperative blood glucose, and preoperative and postoperative insulin level
* evaluated for any hyperglycaemia-related complications

Conditions

  • Diabetes Mellitus Type 2

Interventions

OTHER

preoperative carbohydrate loading

Patients receive 200 ml drink containing Maltodextrin 12.5%, 2 hours prior to surgery

OTHER

Placebo

Patients receive 200 ml regular drinking water with zero-calorie sweetener, 2 hours prior to surgery

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-22
Primary Completion
2023-12-20
Completion
2024-01-31

Countries

  • Indonesia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06687811 on ClinicalTrials.gov